5 papers and 0 clinical trials exploring ayahuasca as a treatment for equity and ethics.
Ayahuasca is a botanical decoction combining DMT with MAO-inhibiting harmala alkaloids, producing intense psychedelic effects lasting 3-6 hours. Clinical trials show rapid, large antidepressant effects from a single dose, with a favourable safety profile in controlled settings.
Full Ayahuasca profileEquity and ethics in psychedelic research is a vital and complex topic, addressing the need for fair access and representation in clinical trials, as well as the stewardship of traditional knowledge. The involvement of Indigenous communities, who have historically used these substances, must be safeguarded against exploitation as the field matures.
Full Equity and Ethics profileNo clinical trials have been tagged with both Ayahuasca and Equity and Ethics yet.
Trials are continuously being added as new studies are registered.